ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.105
-0.215 (-16.31%)
Apr 2, 2025, 1:34 PM EDT - Market open

ABVC BioPharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2014 - 2018
Market Capitalization
149209610584
Upgrade
Market Cap Growth
93.67%-55.74%-78.95%-8.30%24.82%-80.39%
Upgrade
Enterprise Value
1912229510987
Upgrade
Last Close Price
1.321.166.2533.9051.0043.70
Upgrade
PS Ratio
26.0058.7220.85269.96216.85119.59
Upgrade
PB Ratio
1.891.106.2510.8339.35-672.31
Upgrade
P/TBV Ratio
0.981.076.5310.8630.46-
Upgrade
EV/Sales Ratio
36.6880.2422.60266.23225.32124.60
Upgrade
Debt / Equity Ratio
0.340.301.060.382.54-39.56
Upgrade
Asset Turnover
0.030.010.080.030.050.11
Upgrade
Inventory Turnover
---0.39-30.56
Upgrade
Quick Ratio
0.050.030.181.720.970.08
Upgrade
Current Ratio
0.340.280.542.071.270.13
Upgrade
Return on Equity (ROE)
-102.31%-191.96%-269.48%-208.73%-835.04%-
Upgrade
Return on Assets (ROA)
-25.30%-42.67%-81.16%-57.83%-57.36%-33.60%
Upgrade
Return on Capital (ROIC)
-33.19%-59.60%-100.17%-67.64%-74.68%-220.20%
Upgrade
Earnings Yield
-51.00%-117.48%-81.21%-13.37%-9.35%-4.34%
Upgrade
FCF Yield
-11.11%-47.56%-37.18%-7.93%-4.36%-3.74%
Upgrade
Buyback Yield / Dilution
-187.47%-36.92%-26.39%-27.07%-12.67%-47.26%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q